Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
RF Micro Devices Inc. (NASDAQ: RFMD) shares closed up 9.41 percent on Wednesday with about 37.5 million shares traded. The stock was one of the biggest gainers on the NASDAQ. RF Micro Devices reported net profit of $36.4 million, or 13 cents a share, which met analysts' EPS expectations. It also marked an increase from net profit of $21.3 million and earnings of 8 cents a share, in the same period one year earlier. Canaccord reiterated its "buy" rating on the stock and even increased its target price to $7.25.
Get more information on RF Micro Devices Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/RFMD
EZCORP, Inc. (NASDAQ: EZPW) shares closed up 20.32 percent on Wednesday with 4.5 million shares traded. The stock was one of the biggest gainers on the NASDAQ and posted one of the largest volume advances. The gains came after the pawn shop operator announced first-quarter earnings per share that exceeded analysts' expectations. The company reported adjusted earnings of 49 cents per share in the quarter that ended Dec. 31, which surpassed analysts' expectations of 39 cents a share.
Get more information on EZCORP, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/EZPW
Gray Fox Petroleum Corp. (OTCBB: GFOX) shares closed down 17.13 percent on Wednesday with nearly 900,000 shares traded. The stock was one of the biggest decliners in the OTCBB marketplace. There was no significant news to explain the decline. Gray Fox Petroleum Corp. does not have significant operations. It intends to explore alternative business opportunities in the oil and gas industry.
Get more information on Gray Fox Petroleum Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/GFOX
Elite Pharmaceuticals, Inc. (OTCBB: ELTP) shares closed up 6.94 percent on Wednesday with about 3.9 million shares traded. The stock was one of the most active stocks in the OTCBB market. Earlier in the month the company announced the first dosing of a pivotal bioequivalence study in healthy volunteers for an undisclosed opioid abuse deterrent product utilizing Elite's proprietary pharmacological abuse deterrent technology.
Get more information on Elite Pharmaceuticals, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ELTP
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.